InvestorsHub Logo
Followers 36
Posts 20235
Boards Moderated 0
Alias Born 07/10/2015

Re: Winsor1 post# 18327

Friday, 08/24/2018 3:56:32 PM

Friday, August 24, 2018 3:56:32 PM

Post# of 41321

Also Amedica has ongoing relationships with multiple corporate partners and has collaborating with them very actively on the development and commercialization of silicon nitride outside the spine market. These relationships are very significant and were all made possible entirely by partners attracted to the strength of our R&D platform



This suggests, try as hard as some big ortho companies might, there is no stopping Si3N4. The tech seems just too good on all major aspects of orthopedic implants and with its wide ranging adaptability.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News